3,4,6,7,8,9-Hexahydropyrazino[1,2-a]indol-1(2H)-one, 98+%, 250mg

6-((6-(Hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide, 98%, 5mg

((2S,4R)-4-Methoxypyrrolidin-2-yl)methanol, 98%, 5g

n-Ethyl-4-nitroaniline, 97%, 10g

4-Methyl-8-nitroquinoline, 95%, 250mg

4,6,8-Trimethylquinoline>98.0%(GC)(T)1g

1-Chloro-2-propanol (contains ca. 25% 2-Chloro-1-propanol)>70.0%(GC)25mL

3-Octen-2-one, 97% GC, 1g

2-(3-nitrophenyl)-1,3,4-oxadiazole, 250mg

Ethyl (3,4-dichlorobenzoyl)acetate, 95.0%, 100mg

1-Chloro-3-ethoxy-2-methyl-benzene, 1g

ETHYL (2R,4R)-1-BOC-4-METHYL-5-OXOPYRROLIDINE-2-CARBOXYLATE, 95.0%, 250mg

Kjeldahl tablets, (Wieninger catalyst) tablet 2.5 g, 1000 pieces, plastic packaging.